Gennex Laboratories Ltd

AI
Gennex Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Gennex Laboratories Ltd

₹ 10.8 13.30%
14 Aug - close price
gennexlab.com BSE: 531739
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

Website BSE
  • Market Cap ₹ 263 Cr.
  • Current Price ₹ 10.8
  • High / Low ₹ 17.2 / 7.05
  • Stock P/E 14.0
  • Book Value ₹ 9.16
  • Dividend Yield 0.00 %
  • ROCE 10.8 %
  • ROE 9.25 %
  • Face Value ₹ 1.00
Edit ratios
Unsung hero
Tiruppur Kumaran
He died at 27 after a police assault on a protest march. Even while collapsing from his injuries, he held the banned national flag tightly and kept it from touching the ground.
Unsung hero
Bhikubhai Gomansinh Solanki
He helped liberate Dadra and Nagar Haveli. He coordinated with freedom fighters and captured Naroli during floods. People of Naroli called him Kazi because he resolved their problems.

Pros

  • Stock is trading at 1.18 times its book value
  • Company has delivered good profit growth of 34.4% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 23.6%
  • Tax rate seems low
  • Company has a low return on equity of 9.82% over last 3 years.
  • Debtor days have increased from 68.2 to 92.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
16.52 18.18 21.39 35.52 28.32 33.38 40.01 40.33 34.18 39.30 42.96 60.96 39.84
11.42 12.41 16.59 29.26 24.10 25.92 32.86 38.31 29.11 31.74 34.39 55.07 35.46
Operating Profit 5.10 5.77 4.80 6.26 4.22 7.46 7.15 2.02 5.07 7.56 8.57 5.89 4.38
OPM % 30.87% 31.74% 22.44% 17.62% 14.90% 22.35% 17.87% 5.01% 14.83% 19.24% 19.95% 9.66% 10.99%
0.00 0.00 0.00 0.00 2.47 0.00 0.00 3.68 2.28 0.00 -0.30 1.02 2.01
Interest 0.73 0.78 0.83 0.73 0.73 0.22 0.84 1.20 0.98 1.03 1.11 1.08 0.57
Depreciation 0.65 1.03 0.45 0.23 0.45 1.11 0.50 0.54 0.50 0.47 0.52 1.16 0.90
Profit before tax 3.72 3.96 3.52 5.30 5.51 6.13 5.81 3.96 5.87 6.06 6.64 4.67 4.92
Tax % 23.39% 22.47% 21.31% 15.28% 15.43% 12.23% 12.91% 22.22% 14.48% 9.08% 9.79% 4.50% 5.08%
2.85 3.07 2.76 4.50 4.66 5.38 5.06 3.07 5.01 5.51 6.00 4.46 4.67
EPS in Rs 0.16 0.17 0.15 0.20 0.19 0.21 0.20 0.10 0.20 0.21 0.22 0.15 0.18
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
42 44 56 56 60 61 66 87 138 173 183
37 42 52 52 53 56 61 70 121 150 157
Operating Profit 5 2 4 3 7 5 5 17 17 22 26
OPM % 11% 5% 7% 6% 11% 9% 7% 20% 12% 13% 14%
0 1 1 1 0 1 4 5 10 8 3
Interest 1 1 1 1 1 1 1 3 4 4 4
Depreciation 1 1 1 1 1 1 1 2 2 3 3
Profit before tax 3 1 3 3 5 5 6 16 21 23 22
Tax % 13% 42% 26% 27% 20% 23% 23% 20% 15% 10%
3 1 2 2 4 4 5 13 18 21 21
EPS in Rs 0.14 0.04 0.12 0.10 0.21 0.21 0.28 0.58 0.80 0.76 0.76
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 24%
3 Years: 38%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 34%
3 Years: 57%
TTM: 14%
Stock Price CAGR
10 Years: 5%
5 Years: 5%
3 Years: 8%
1 Year: -11%
Return on Equity
10 Years: 9%
5 Years: 10%
3 Years: 10%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 13 13 13 13 13 13 18 23 23 24
Reserves 18 19 21 23 27 31 62 148 164 198
4 2 5 5 7 10 1 6 10 79
14 16 13 16 12 14 51 54 59 47
Total Liabilities 49 50 52 57 59 68 132 230 256 349
16 16 16 15 14 14 74 56 60 61
CWIP 0 0 0 0 0 0 0 2 5 13
Investments 7 7 7 7 7 7 0 0 0 0
26 28 29 35 38 48 59 172 191 275
Total Assets 49 50 52 57 59 68 132 230 256 349

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0 3 2 -2 -1 12 24 -47 -11 -64
-1 -1 -1 -0 -0 -2 -38 19 1 -5
1 -2 1 -0 2 -2 21 74 5 65
Net Cash Flow -0 0 2 -2 0 8 6 46 -5 -3
Free Cash Flow -1 2 1 -2 -2 10 -16 -31 -20 -76
CFO/OP 13% 190% 55% -52% 1% 242% 505% -274% -45% -274%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 90 87 68 41 55 67 52 75 37 92
Inventory Days 43 31 57 78 50 72 139 184 133 153
Days Payable 139 161 88 86 59 72 63 111 49 58
Cash Conversion Cycle -7 -43 38 34 46 67 129 148 122 187
Working Capital Days 74 75 56 87 108 87 23 255 214 295
ROCE % 6% 11% 8% 14% 12% 11% 14% 13% 11%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Foreign Exchange Earned (Export Revenue)
Rs Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
count
Capacity Utilization
%
Installed Capacity
TPA
Total Production Volume
TPA
Top 4 Products Share of Production
%
Number of Focus APIs
count
Number of Licensed APIs
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
23.61% 23.61% 18.41% 18.41% 18.41% 18.41% 18.41% 19.82% 23.62% 23.62% 23.63% 23.63%
76.39% 76.39% 81.58% 81.57% 81.59% 81.58% 81.58% 80.17% 76.38% 76.39% 76.36% 76.38%
No. of Shareholders 50,98869,72383,99687,82090,23692,50692,32691,18390,32086,30684,13382,886

Documents

Announcements

Annual reports

Right Issue